Patents Issued Covering Stable Tablet Formulation and Once Daily Dosing Regimen for Kuvan
NOVATO, Calif., July 30, /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) announced today that the United States Patent Office has issued patents covering stable tablet formulation and the approved once daily dosing regimen for Kuvan(R) (sapropterin dihydrochlorid...Expert Statement Issued about Lantus(R) Following Recent Publications in Diabetologia
BRIDGEWATER, N.J., July 15 /PRNewswire-FirstCall/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY ) announced today the release of an Expert Statement by a multidisciplinary board of renowned international experts following an in-depth assessment of the recent publications of registry...Viral Genetics Has Option Under Issued Key Patent for Cancer Drug
SAN MARINO, Calif., May 21 /PRNewswire-FirstCall/ -- Biotechnology firm Viral Genetics, Inc. (Pink Sheets: VRAL), a company that discovers and develops drug compounds to treat cancer, Lyme Disease and HIV, has been issued a patent for novel cancer therapies. The patent protects cancer drugs that h...Healthcare Reform Resolution Issued by National Hospice and Palliative Care Organization
ALEXANDRIA, Va., May 1 /PRNewswire-USNewswire/ -- With the healthcare reform debate picking up pace in all corners of the country, the National Hospice and Palliative Care Organization's board of directors issued a Healthcare Reform Resolution on April 21 that calls attention to critical facto...Patent Issued for UNIVAL(R) D3(TM) Data Conversion System
Medical Record Data Conversion System Receives Patent ANN ARBOR, Mich., April 14 /PRNewswire/ -- UNIVAL, Inc. has been notified that a patent has been issued for its Digital Data Direct (TM) data conversion system. Digital Data Direct (D3 (TM) ) is used to convert paper medical records to da...Press Statement Issued by Ranbaxy Laboratories Limited
GURGAON, India, Feb. 25 /PRNewswire/ -- Ranbaxy has just received a letter and information indicating that all pending and approved ANDAs from Ranbaxy's Paonta Sahib facility have been added to a list maintained under a policy entitled "Application Integrity Policy" or "AIP". Ranbaxy will analyze...Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC
BOSTON, July 30 /PRNewswire/ -- Scimitar Equity, LLC issues a review of Generex Biotechnology Corporation (Nasdaq: GNBT ), entitled, "RapidMist(TM), the Non-Invasive Oral Drug Delivery Platform, Sets the Tone as Best in Class Followed by an Expanding Pipeline and Global Revenues." This revi...Advaxis, Inc Initiation Coverage Review Issued By Scimitar Equity, LLC
BOSTON, July 15 /PRNewswire/ --Scimitar Equity, LLC issues a review of Advaxis, Inc (OTC Bulletin Board: ADXS), entitled, "The New Generation of Cancer Immunotherapeutics". This review is available at website: http://www.scimitarequity.com . Based in North Brunswick, New Jersey, Advaxis, ...Initiation of Coverage Informational Review Issued by Scimitar Equity Research
BOSTON, Dec. 17 /PRNewswire/ -- Scimitar Equity Research, Inc. issues a review on Nventa Biopharmaceuticals Corporation (TSX: NVN) entitled: "A Very Promising Therapeutic and Vaccine Candidate for the Treatment of Diseases Caused by the Human Papillomavirus (HPV)." The analyst research is avai...Tiny Cup Attached to Eye Improves Drug Delivery For Retinal Diseases
...ce 1932. It is a national leader in pediatric research. For more information, see www.TheVisionCenterAtCHLA.org . This news release was issued on behalf of Newswise(TM). For more information, visit http://www.newswise.com . CONTACT: James Harris, +1-310-398-5565, jtharris5@ca.rr....Regular Yoga Practice Is Associated With Mindful Eating
... and passion for health, knowledge and hope to their work and to the world. For more information, please visit fhcrc.org. This news release was issued on behalf of Newswise(TM). For more information, visit http://www.newswise.com. Media Contacts: Kristen Woodward 206-667-50...Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009
...uding Abbott, are commercializing. As an innovator in RNA-based drug discovery and development, Isis is the owner or exclusive licensee of over 1,600 issued patents worldwide. Additional information about Isis is available at www.isispharm.com . This press release includes forward-looking statem...Paradigm II Compliance Software for CLIA compliance
Description:...ced cross-referencing system ( Para-Links ) and State-of-the-art event scheduling adaptable to any Lab environment. Action Item notifications can be issued via corporate e-mail for all required tasks, and can be managed directly from an easy-to-use, dashboard interface. The Paradigm II suite of mo...Anthrax Vaccine Immunization Program
... , the Clinton administration required the inoculation of all military members [2] [3] , despite the fact that the Food and Drug Administration (FDA) issued a warning letter to the anthrax vaccine manufacturer threatening to revoke its product licenses unless immediate action was taken to correct deficienc...e-Smart Technologies Responds to Press Release Issued By IDsmart LLC
NEW YORK, Nov. 14 /PRNewswire-FirstCall/ -- e-Smart Technologies, Inc. (Pink Sheets: ESMT) ("e-Smart" or the "Company") responds as follows to the press release issued by IDsmart in which a series of serious allegations are made regarding e-Smart Technologies, Inc. and which e-Smart hereby ref...Patent Issued for e-Smart Technologies, Inc.'s First Biometric Match-on-Card Technology
NEW YORK, Nov. 5 /PRNewswire-FirstCall/ -- e-Smart Technologies, Inc. (Pink Sheets: ESMT); ("e-Smart") with its parent company IVI Smart Technologies, Inc. ("IVI") (hereinafter, collectively the "Company") is pleased to announce that the United States Patent and Trademark Office has issued a p...New guidelines to fight obesity in pregnancy issued
WHITE PLAINS, N.Y. MAY 28, 2009 -- Starting pregnancy at a healthy weight and gaining the right amount during pregnancy is critical to giving a baby a healthy start in life, the March of Dimes said today in response to new guidelines from the Institute of Medicine (IOM). The Institute of Medic...Nanogen Issued Patent for Electronic Microarray With Memory
Nanogen, Inc. (Nasdaq: NGEN), developer of advanced diagnostic products, announced today that it was issued U.S. Patent No. 6,867,048, "Multiplexed Active Biologic Array" by the U.S. Patent and Trademark Office. The '048 patent relates to a method of addressing one or more electrodes (or "test site...Nottinghamshire Police First Law Enforcement Agency to Deploy ForensicSoft in United Kingdom
...o@forensicsoft.com . Press Contact: Neil Bryant nbryant@forensicsoft.com +1 (401) 580-7619 This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com . ...M2SYS Technology to Offer Desktop Biometric Technology to Kronos Customers
... Kronos uniquely delivers complete automation and high-quality information in an easy-to-use solution, visit www.kronos.com . This release was issued on behalf of the above organization by Send2Press(R), a unit of Neotrope(R). http://www.Send2Press.com ...Orexigen(R) Therapeutics Issued a Key Fourth U.S. Patent on Contrave(R)
SAN DIEGO, Jan. 5 /PRNewswire-FirstCall/ -- Orexigen(R) Therapeutics, Inc. (Nasdaq: OREX ), a biopharmaceutical company focused on the treatment of obesity, today announced that the United States Patent and Trademark Office (USPTO) has issued a patent for what the Company refers to as the "W...Arobella Medical CEO is Issued U.S. Patent for Ultrasound Wound Therapy Technology
Patent will protect next generation of Qoustic Wound Therapy System(R) MINNEAPOLIS, Oct. 9 /PRNewswire/ -- Arobella Medical, LLC, a leader in advanced ultrasonic wound care devices, today announced that its Co-founder, President and CEO Eliaz Babaev, Ph.D., has been issued a U.S. patent that ...Neurobiological Technologies, Inc. (Nasdaq: NTII) Q4/08 Review Issued by Scimitar Equity, LLC
BOSTON, Sept. 18 /PRNewswire/ -- Scimitar Equity, LLC issues a Q4/08 review of Neurobiological Technologies, Inc. (Nasdaq: NTII ), entitled, "Defining Outcome Scenarios, Probabilities Appear Focused to the Upside and Future Appreciation." This review is available at our website: http://www.s...VioQuest Pharmaceuticals, Inc Q2/08 Review Issued by Scimitar Equity, LLC
BOSTON, Aug. 25 /PRNewswire/ -- Scimitar Equity, LLC issues a review of VioQuest Pharmaceuticals, Inc (OTC Bulletin Board: VOQP), entitled, "Creating Value; Turnaround Leverages Product Opportunities while Expectation Abounds and Losses Decrease." This review is available at website: http:/...VioQuest Pharmaceuticals, Inc Valuation Upgrade Review Issued By Scimitar Equity, LLC
BOSTON, July 29 /PRNewswire/ -- Scimitar Equity, LLC issues a review of VioQuest Pharmaceuticals, Inc (OTC Bulletin Board: VOQP), entitled, "510k Application Submitted for Xyfid(TM) and Priority Review Voucher for Lenocta(TM) Focuses Milestones and Share Price Appreciation." This review is a...